In a move to bolster its drug manufacturing capabilities in the United States, Thermo Fisher has purchased a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

Under the expanded partnership, Thermo Fisher will acquire Sanofi's sterile fill-finish and packaging facility in Ridgefield, N.J. The science-services and instruments provider said Wednesday that it ...

Thermo Fisher Scientific Inc. (NYSE: TMO) is one of Goldman Sachs’ top healthcare stock picks. On June 25, the company ...

Thermo Fisher is acquiring Solventum’s Purification & Filtration business for $4.1 billion to dominate biologics ...

As of fiscal year-end 2024, Thermo Fisher carried roughly $31 billion in long- and short-term obligations. The PPD acquisition materially increased its leverage but the number has steadily come down.

Thermo Fisher Scientific is reportedly planning to divest parts of its diagnostics unit for approximately $4 billion to focus on higher growth assets. This move is expected to impact the financial ...

Thermo Fisher Scientific (NYSE:TMO) recently made headlines by entering a collaboration with Ethris GmbH to advance mRNA solutions and putting a $4 billion price tag on part of its diagnostics ...

Thermo Fisher's 2025 headwinds from tariffs and US research funding cuts are real but temporary. Read why TMO stock is a Strong Buy.

Conclusion Thermo Fisher was priced for perfection in January near $600, and we got a lot of imperfection in the form of slow growth plus tariff and fiscal policy headwinds.

Life sciences company Thermo Fisher (NYSE:TMO) will be reporting earnings tomorrow before the bell. Here’s what to expect.

Thermo Fisher Scientific’s proposal to build a new corporate aircraft hangar and office at Pease in Portsmouth gains approval.

Thermo Fisher Scientific CIO Ryan Snyder believes business strategy and tech strategy should be woven together and that data should be co-owned across the company.